Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment
Lu C, Fu W, Zhou R, Hu W. Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment. BMC Complementary Medicine And Therapies 2020, 20: 37. PMID: 32024508, PMCID: PMC7076828, DOI: 10.1186/s12906-020-2815-y.Peer-Reviewed Original ResearchConceptsHepatitis BCompound-target networkNetwork pharmacology-based studyTraditional Chinese medicinal compoundHepatitis B treatmentFavorable treatment effectChinese medicinal compoundsDisease target networkTraditional Chinese medicine preparationChinese medicine preparationEnrichment analysisPharmacological mechanismsMedicine DatabaseConclusionThis studyChinese Medicine DatabaseProtein-protein interaction networkDisease targetsDisease databaseMedicine preparationTreatment effectsActive compoundsB treatmentHB treatmentTreatmentCapsule